Compare PRTS & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTS | BNGO |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 24.3M |
| IPO Year | 2007 | 2018 |
| Metric | PRTS | BNGO |
|---|---|---|
| Price | $0.72 | $1.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $0.70 | ★ $6.33 |
| AVG Volume (30 Days) | ★ 776.3K | 294.1K |
| Earning Date | 03-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $560,632,000.00 | $28,720,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.37 | $1.06 |
| 52 Week High | $1.36 | $6.32 |
| Indicator | PRTS | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 76.99 | 25.96 |
| Support Level | $0.48 | $1.07 |
| Resistance Level | $0.59 | $1.23 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 87.15 | 7.14 |
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.